With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

Glaucoma, the second leading cause of blindness globally, affects millions and is projected to reach 111.8 million cases by ...

The agency wants applicants to demystify their algorithms and provide specific details about what the models do, how they’re ...

Stay updated on the volatile share price of Recursion, a biotech company with a maturing pipeline and potential for growth ...

Over a video call, Alex Zhavoronkov holds up a small, green, diamond-shaped pill. It has been developed by his company to ...

A middle school student in Chicago made headlines by uncovering a remarkable medical breakthrough hidden in a surprising ...

Our fair value estimate for WuXi is HKD 24.60 per share. WuXi has been growing at a CAGR of 53.3% for the past eight years. Although its USD 20.5 billion total backlog revenue supports our growth ...

With the intensification of global population aging, muscle atrophy, characterized by the loss of muscle mass and function, has become an important health issue affecting the elderly. Researchers have ...